Ketomar
Active Ingredient
Ketotifen.
Indication
Symptomatic treatment of allergic conditions including rhinitis & conjunctivitis. Prophylactic treatment of bronchial asthma.
Dosage & Administration
Adults : 1 mg twice daily with food. If necessary the dose may be increased to 2 mg twice daily in severe cases. Children above 3 years : 1 mg twice daily with food. Patients known to be easily sedated should begin treatment with 0.5 to 1 mg at night for the first few days or as directed by the physician. Use in elderly : Same as adult dose or as advised by the physician.
Contraindication & Precaution
A reversible fall in the platelet count has been observed in a few patients receiving Ketotifen concomitantly with oral antidiabetic agent & it has been suggested that this combination should therefore be avoided. Although there is no evidence of any teratogenic effect, recommendations for Ketotifen in pregnancy or when breast feeding can not be given. It is important to continue the previous treatment for a minimum of two weeks after starting Ketotifen to avoid the possibility of exacerbation of asthma. This applies specially to systemic corticosteroids & ACTH because of the possible existence of adrenocortical insufficiency in steroid dependent patient.
Side Effect
Drowsiness & in isolated cases, dry mouth & slight dizziness may occur at the beginning of treatment but usually disappear spontaneously after a few days.
Preparation
1 mg Tablet, 1 mg/ 5 ml Syrup
Active Ingredient
Ketotifen.
Indication
Symptomatic treatment of allergic conditions including rhinitis & conjunctivitis. Prophylactic treatment of bronchial asthma.
Dosage & Administration
Adults : 1 mg twice daily with food. If necessary the dose may be increased to 2 mg twice daily in severe cases. Children above 3 years : 1 mg twice daily with food. Patients known to be easily sedated should begin treatment with 0.5 to 1 mg at night for the first few days or as directed by the physician. Use in elderly : Same as adult dose or as advised by the physician.
Contraindication & Precaution
A reversible fall in the platelet count has been observed in a few patients receiving Ketotifen concomitantly with oral antidiabetic agent & it has been suggested that this combination should therefore be avoided. Although there is no evidence of any teratogenic effect, recommendations for Ketotifen in pregnancy or when breast feeding can not be given. It is important to continue the previous treatment for a minimum of two weeks after starting Ketotifen to avoid the possibility of exacerbation of asthma. This applies specially to systemic corticosteroids & ACTH because of the possible existence of adrenocortical insufficiency in steroid dependent patient.
Side Effect
Drowsiness & in isolated cases, dry mouth & slight dizziness may occur at the beginning of treatment but usually disappear spontaneously after a few days.
Preparation
1 mg Tablet, 1 mg/ 5 ml Syrup
0 Reviews:
Post Your Review